Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowInflammatory Bowel Diseases publishes original basic science, translational, and clinical research regarding pathogenesis, epidemiology, evaluation, and treatment of IBD that will lead to advancements in overall clinical care.
Looking to publish in Inflammatory Bowel Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Inflammatory Bowel Diseases accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Articles
Brief Reports
Letters To The Editor
Clinical Practice Guidelines
Recent Publications
Editorial: Epidemiology of IBD in Malaysia: a rare longitudinal lens in Asia
Sarita Shrestha, Gilaad G Kaplan
Correction to: Characterization of mesocolic adipose hyperplasia in a rat 2,4,6-trinitrobenzenesulfonic acid colitis model and comparison to creeping fat in Crohn disease
-
Response to: The Long Game in Ulcerative Colitis: Mirikizumab’s Four-Year Outcomes
David B Clemow
Ustekinumab resistance in individuals with ulcerative colitis is associated with an alteration of a subset of proinflammatory mucosal regulatory T cells
Kristi C Briggs, Ada Tam, Lara Chaaban, Adam Luo, Lynn Kobeissi, Mark Lazarev, Alyssa Parian, Reezwana Chowdhury, Florin M Selaru, Kelly Casella, Eugene Shenderov, Cynthia L Sears, Franck Housseau, Joanna M P Melia, Drew M Pardoll
Quality of healthcare delivery in inflammatory bowel disease pregnancy: a scoping review
Simone Chin, Kathryn Demase, Crispin Corte, Darren Wong, Ralley Prentice, Peter De Cruz
Frequently asked questions
How long does it take to publish?
Appeals may take a minimum of 3 to 6 weeks to receive a response from the Editors. Proof corrections must be returned within 48 hours of receipt.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumIs a cover letter required?
Cover letters are mentioned for disclosure when sharing prior IBD reviews with another journal. Manuscripts posted to a preprint server must be disclosed during submission. AI use should be disclosed in cover letters to editors and in the Methods or Acknowledgements section.
Reformat to Inflammatory Bowel Diseases using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access publishing options available.
Reformat to Inflammatory Bowel Diseases using Livewrite Premium